Cytokine-blocking monoclonal antibody helps prevent asthma exacerbations
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...
When it comes to lung cancer, the patient and the physician often feel like Danny in The Shining, navigating...
According to recent cases, the SARSCOV2 had undergone a viral mutation that increases viral replication in the lungs, thus...
Scientific developments typically require a good deal of time and money. Sadly, those two resources are not always in...
This year would probably be remembered as one of the darkest times of the 21st century. The amount and...
COVID-19 is known for its adverse pulmonary effect for those affected. However, studies have shown that this disease can...
The SARS-CoV2, a novel coronavirus causing the COVID-19, has already infected more than five million people in the entire...
How morbid are comorbidities: COVID-19 comorbidities and how they affect prognosis COVID-19 would give an individual a critical state when...
The novel coronavirus (nCoV-19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crisis...
A recent report by the Centers for Disease Control (CDC) in the US raised concerns regarding the use of...